Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States
Description
CONCLUSION: The direct health care costs of SARS-CoV-2, particularly among adults aged 50 years or older, would be substantially reduced by administering a second dose 5 months after the initial dose.
